PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Cancer. Author manuscript; available in PMC Aug 9, 2010.
Published in final edited form as:
PMCID: PMC2917801
NIHMSID: NIHMS209728
Aging in the Context of Cancer Prevention and Control
Perspectives From Behavioral Medicine
Keith M. Bellizzi, PhD, MPH,1,2 Karen M. Mustian, PhD,3 Deborah J. Bowen, PhD,4 Barbara Resnick, PhD, CRNP,5 and Suzanne M. Miller, PhD6
1 Human Development and Family Studies, University of Connecticut, Storrs, Connecticut
2 Office of Cancer Survivorship, National Cancer Institute, Bethesda, Maryland
3 Behavioral Medicine Unit, James P. Wilmot Cancer Center, University of Rochester, Rochester, New York
4 Department of Social and Behavioral Sciences, Boston University, Boston, Massachusetts
5 University of Maryland School of Nursing, Baltimore, Maryland
6 Behavioral Research and the Psychological and Behavioral Medicine Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania
Address for reprints: Keith M. Bellizzi, Human Development and Family Studies, University of Connecticut, 348 Mansfield Road, Unit 2058, Storrs, CT 06269-2058; Fax: (860) 486-3452; keith.m.bellizzi/at/uconn.edu
Keith M. Bellizzi’s current address: Human Development and Family Studies, University of Connecticut, Storrs, Connecticut.
Men and women aged ≥65 years represent approximately 12% (36.8 million) of the US population and this number is expected to double by the year 2030.1 The fastest growing segment of the population is the “oldest old,” those aged ≥85 years. Projections suggest that the oldest old will have increased in number from 3.7 million in 1996 to 5.7 million in 2010 and could reach 18.2 million by 2050.1 Research clearly demonstrates that the risk of cancer increases with age.2,3 Approximately 60% of all incident malignancies in the US occur in adults aged ≥65 years and 16% of those aged ≥65 years have a history of cancer.2 Although cancer is the second leading cause of death among men and women aged ≥65 years,1 many older adults are in fact surviving cancer. In the US alone, it is estimated that 6.5 million of the 10.8 million cancer survivors are aged ≥65 years, with the oldest old comprising 15% of this 6.5 million (Fig. 1). Approximately 43% of these elderly men and women with cancer survive >10 years and approximately 17% survive >20 years from the time of their initial diagnosis.2
FIGURE 1
FIGURE 1
Estimated number of cancer survivors aged >65 years in the US on January 1, 2004 by age group (invasive/first primary tumor cases only [N = 6.5 million survivors aged >65 years]). Data source: Surveillance, Epidemiology, and End Results (more ...)
For many older adults, cancer appears to be joining the ranks of other age-related chronic diseases, but the post-treatment burden of the disease (eg, loss of physical function, permanent disability, fatigue, insomnia, depression, anxiety, and economic devastation) is relatively unknown in this growing population. We know from studies of pediatric and younger adult cancer survivors that cancer and its treatment can result in years of physical and mental distress for some individuals.4,5 These chronic consequences can significantly impair the health and quality of life of cancer survivors and their caregivers beyond what is typical of adults without cancer. The chronic physical and mental distress associated with cancer survivorship exacerbates and is exacerbated by the additional comorbid conditions (eg, hypertension, hypercholesterolemia, osteoporosis, diabetes, and dementia) often present in adults aged ≥65 years69 and health disparities are typically present in underserved populations because of age, sex, race, sexual orientation, and nationality. It is imperative that healthcare practitioners and researchers from disparate disciplines collectively focus efforts toward gaining a better understanding of what the consequences of cancer and its treatments are for older adults and how to appropriately meet the multifaceted medical and psychosocial needs of this growing population. Preventing and attenuating the chronic consequences of cancer and its treatments among older adults is critical to improve not only the individual’s quality of life but also to reduce the additional public health burden on the US healthcare system. At the same time, cancer care for older adults should extend throughout the illness and incorporate appropriate palliative management at the end of life for those who will die at an advanced age, particularly the oldest old.
The cancer and aging trends described above illustrate a major public health challenge that healthcare professionals will soon face in caring for this growing population. Unfortunately, to our knowledge, evidence–based practice guidelines regarding the short–term and long–term management of cancer, including palliative care, is sparse for this group and it would be inappropriate to extrapolate from extant studies on younger populations because older adults are physiologically, psychologically, and socially different from younger adults.1012 The aging process involves several normative physiologic changes, such as increases in blood pressure, arteriosclerosis, the reduced effectiveness of cytotoxic T lymphocytes and natural killer cells, functional changes in the gastrointestinal system and lungs, and an overall decrease in reserve capacity.10,13 The extent to which age-related physiologic changes affect disease progression, response to treatment, survivorship, and the management of palliative care issues in older adults is unknown. Unlike younger adults, the experience of cancer in the elderly is often superimposed on existing health conditions, including heart disease, arthritis, diabetes, and various geriatric syndromes that affect older adults.7,14,15 These coexisting medical conditions, often the focus of cancer and aging research, can complicate prevention and screening efforts and the efficacy of and extent of the treatment offered, as well as older adults’ response to treatment and post-treatment health and well-being. From a psychologic standpoint, the gerontology literature reveals that many older adults perceive less control over their health, experience fewer emotional highs and lows, and adjust their expectations and attitudes regarding their current state of health and/or ability to recover from adverse health events as they age.11,1618 In addition, many older adults have had previous experiences with health issues, multiple cancer diagnoses, and other life losses due to their placement in the life course.19 The extent to which life experiences influence current beliefs and attitudes regarding prevention and screening practices or resiliency during the survivorship experience warrants consideration as the nascent field of cancer and aging evolves. Socially, growing older brings about some important changes in work life, relationships with family and friends, and roles and responsibilities.12,17 Given that older adults have many more options today to be active members of their community, the timing of changes and the extent to which modifications in roles and responsibilities affect the older adult’s health can vary greatly. Research suggests that older adults, who do not replace previous social roles, can end up socially isolated, which can ultimately lead to poorer health outcomes.20 Understanding aspects of social development (ie, role continuity, role loss, and role gain) are important considerations, often overlooked in oncology, for future research on older individuals with cancer.
These developmental domains also need to be considered when providing palliative care to patients who will die of their cancer or competing health conditions. Assessing a person’s psychologic, social, and existential response to illness, as well as medical aspects of the disease, is an important feature of whole–patient palliative care and disease management.21,22 Understanding patient and family preferences and desires for care, including hospice care, extent of palliative care, and advanced directives, are also critical elements of comprehensive cancer care.
As we age, we become more heterogeneous in terms of physical and psychosocial health as a result of our previous lifestyle, environmental exposure, and genetic composition.13 As a result, age should not be used as a proxy for health status23 and categorizing men and women aged ≥65 years as 1 homogeneous group does a disservice to the population that we are trying to serve. In the US, an elderly person is arbitrarily defined as someone aged ≥65 years for bureaucratic reasons, yet many healthcare professionals make critical medical care decisions based on this artificial cutoff.24 New strategies are needed to assess the health status of older adults, which could include the use of comprehensive geriatric assessments and performance–based measures, as well as emerging biomarkers of physiologic age.2527 Understanding within–group variations among older adults across the cancer control continuum requires that more attention be paid to aspects of physiologic, psychologic, and social development and less to chronologic age.
Regrettably, research has not kept pace with this rapidly growing segment of our population. Therefore, we are left devoid of information regarding the salient and often complex health issues and needs of this group. Recognizing this gap in knowledge, the Institute of Medicine convened a meeting to elucidate some of the key issues affecting the elderly and how age–related issues can complicate the treatment and acute medical management of cancer.28 In 2007, an entire issue of the Journal of Clinical Oncology was dedicated to the evaluation and treatment of elderly cancer patients.29 Although these 2 publications illustrate some of the important challenges we face in caring for this population, the focus of these 2 efforts were primarily from a medical perspective highlighting cancer and aging issues related to treatment of the disease. To our knowledge, the extent to which the development and integration of psychosocial, behavioral, and biomedical knowledge might help inform the emerging field of cancer and aging has yet to be explored.
Cancer and Aging: Challenges and Opportunities across the Cancer Control Continuum Conference
The Cancer Special Interest Group and the Aging Special Interest Group of the Society of Behavioral Medicine convened a multidisciplinary scientific conference entitled “Cancer and Aging: Challenges and Opportunities across the Cancer Control Continuum” in Washington, DC in March 2007. This conference hosted experts in oncology, behavioral medicine, psychology, public health, gerontology, and geriatrics to formally present on and participate in roundtable discussions concerning the current state of the science among adults aged ≥65 years across the entire cancer control continuum (Fig. 2), with special emphasis on behavioral medicine. In addition, we included a cross-cutting talk on decision making and aging across the continuum because older cancer patients and their healthcare providers make potentially life-altering decisions at different points along this continuum.30,31 The conference was cosponsored by the National Cancer Institute, The American Cancer Society, The Cancer Control Program at the James P. Wilmot Cancer Center at the University of Rochester School of Medicine and Dentistry, and the Lance Armstrong Foundation.
FIGURE 2
FIGURE 2
The cancer control continuum. Adapted from Dr. David Abrams, Brown University School of Medicine, Providence, Rhode Island. Dr. Abrams is currently the Director of the Office of Behavioral and Social Sciences Research at the National Institutes of Health. (more ...)
Invited experts presented current overviews of cancer and aging issues across the cancer continuum: prevention, screening, treatment, survivorship, and end of life. After these didactic lectures, roundtable discussions were held that focused in more detail on summarizing current research, identifying methodologic challenges for research, and prioritizing areas for future research in each of the specific cancer continuum phases. The articles in this special supplemental issue of Cancer summarize the proceedings of this historic conference. These articles are not meant to be comprehensive reviews; rather, they are intended to provide readers with intellectually provoking information regarding some of the complex cancer and aging issues and challenges investigators and healthcare professionals face when conducting research and/or providing cancer-related care for elderly adults.
Miller et al32 provide a brief description of oncologic primary prevention efforts in the geriatric population and highlight several conceptual, methodologic,, and dissemination challenges that arise when applying the primary prevention of cancer to the elderly. Sheinfeld Gorin et al33 present a taxonomy of barriers to screening research and practice among those aged ≥65 years at 3 levels: the macro level (policy and population), the organizational and provider level, and the interindividual and intraindividual level. They propose an agenda for cancer screening research in older populations, based on experiences in both the US and UK. Given and Given34 discuss the importance of behavioral research in the context of cancer treatment and address areas such as comorbidity, function, adverse events and side effects, social and psychologic factors, cognition, and provider behavior. As a complement to the article by Given and Given, Trask et al35 propose several future areas of research worthy of focus in the treatment phase of the cancer continuum. They also discuss the need for transdisciplinary work and behaviorally focused research that is sensitive to differentiating age and cohort effects; understanding the impact of comorbidity; and distinguishing between the influences of age, comorbidity, and performance status. Avis and Deimling36 review research on the physical and mental functioning of older cancer survivors, focusing on studies of those who are newly diagnosed at age ≥65 years as well as research on long-term (≥5 years) cancer survivors who are aged ≥65 years but may have been diagnosed at a younger age. Bellizzi et al37 discuss several of the methodologic challenges investigators face when conducting epidemiologic and cancer clinical trial research with older cancer survivors after treatment as well as directions for future research, new models of care, and the need for transdisciplinary approaches. Saraiya et al38 discuss whether advance care planning, part of end of life planning, allows patients and families to control treatment decisions and minimize the emotional and physical distress and uncertainties that may be part of the final period of life. Reitschuler Cross and Emmanuel39 discuss the notion of providing inbuilt economic resilience against cancer–related financial devastation and suggest that the medical industry, and in particular its cancer care sectors, could take the lead in attending to these consequences of cancer as an integral part of its commitment to comprehensive cancer care. Last, Peters et al40 examine evidence of adult age differences in affective and deliberative information processes, review the sparse evidence regarding age differences in decision making, and introduce the concept of how dual–process theories and their findings might be applied to cancer decision making.
As the cancer and aging field moves forward, both in terms of research and practice, careful consideration needs to be given to some of the complex issues highlighted in this special supplement. It is obvious from these articles that much work remains to be done and that future research must strive to be transdisciplinary, engaging and fostering collaborative efforts among researchers in the fields of oncology, behavioral medicine, geriatrics, gerontology, and palliative medicine. We hope that this special supplement serves as a catalyst for future cancer and aging research and that researchers and practitioners have a better understanding of some of the salient conceptual, methodologic, and practical issues that they will inevitably face in designing and performing oncologic studies and/or providing cancer-related care for aging and elderly adults.
Acknowledgments
Sponsored by the National Cancer Institute’s Office of Cancer Survivorship.
Footnotes
Presented at the Society of Behavioral Medicine preconference entitled “Cancer and Aging: Challenges and Opportunities across the Cancer Control Continuum,” Washington, DC, March 21, 2007.
1. Centers for Disease Control and Prevention and The Merck Company Foundation. The State of Aging and Health in America 2007. Whitehouse Station, NJ: The Merck Company Foundation; 2007. [Accessed on October 25, 2007]. Available at www.cdc.gov/aging and www.merck.com/cr.
2. Surveillance, Epidemiology, and End Results (SEER) Program. Bethesda, Md: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Statistical Research and Applications Branch; [Accessed on October 25, 2007]. Prevalence Database: “US Estimated Complete Prevalence Counts on 1/1/2004” released April 2007, based on the November 2006 SEER data submission. Available at: www.seer.cancer.gov.
3. American Cancer Society. Cancer Facts and Figures. Atlanta, GA: American Cancer Society; 2007.
4. Robison L. The Childhood Cancer Survivor Study: a resource for research of long-term outcomes among adult survivors of childhood cancer. Minn Med. 2005;88:45–49. [PubMed]
5. Zabora J, BrintzenhofeSzoc K, Curbow B, et al. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10:19–28. [PubMed]
6. Yancik R, Havlik RJ, Wesley MN, et al. Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol. 1996;6:399–412. [PubMed]
7. Extermann M. Interaction between comorbidity and cancer. Cancer Control. 2007;14:13–22. [PubMed]
8. Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003;58:82–91. [PubMed]
9. Bellizzi KM, Rowland JH. The role of comorbidity, symptoms and age in the health of older survivors following treatment for cancer. J Aging Health. 2007;3:625–635.
10. Boss GR, Seegmiller JE. Age-related physiological changes and their clinical significance. West J Med. 1981;135:434–440. [PMC free article] [PubMed]
11. Baltes PB, Baltes MM. Psychological perspectives on successful aging: a model of selective optimization with compensation. In: Baltes PB, Baltes MM, editors. Successful Aging: Perspectives From the Behavioral Sciences. New York: Cambridge University Press; 1990. pp. 1–34.
12. Cartensen LL. Social and emotional patterns in adulthood: support for socioemotional selectivity theory. Psychol Aging. 1992;7:331–338. [PubMed]
13. Whitbourne SK. The Aging Individual: Physical and Psychological Perspectives. New York: Springer Publishing Company; 1996.
14. Balducci L. Aging, frailty, and chemotherapy. Cancer Control. 2007;14:7–12. [PubMed]
15. Hurria A. Clinical trials in older adults with cancer: past and future. Oncology. 2007;21:351–358. [PubMed]
16. Brandtstaedter J, Renner G. Tenacious goal pursuit and flexible goal adjustment: explication of age-related analysis of assimilative and accommodative strategies of coping. J Pers Soc Psychol. 1990;65:58–67. [PubMed]
17. Lockenhoff CE, Cartensen LL. Socioemotional selectivity theory, aging, and health: the increasingly delicate balance between regulating emotions and making tough choices. J Pers. 2004;72:1395–1424. [PubMed]
18. Bellizzi KM, Blank TO. Social comparison processes in autobiographies of adult cancer survivors. J Health Psychol. 2006;11:777–786. [PubMed]
19. Mariotto AB, Rowland JH, Ries LAG, et al. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev. 2007;16:566–571. [PubMed]
20. Tomaka J, Thompson S, Palacios R. The relation of social isolation, loneliness and social support to disease outcomes among the elderly. J Aging Health. 2006;18:359–384. [PubMed]
21. Emanuel L, Alexander C, Arnold RM, et al. Integrating palliative care into disease management guidelines. J Palliat Med. 2004;7:774–783. [PubMed]
22. Emanuel L, Alpert H, Baldwin D, et al. What terminally ill patients care about: toward a validated construct of patients’ perspective. J Palliat Med. 2000;3:419–431. [PubMed]
23. Sanderman R, Coyne JC, Ranchor A. Age: a nuisance variable to be eliminated with statistical control or important concern? Patient Educ Couns. 2006;61:315–316. [PubMed]
24. Greenfield S, Blanco DM, Elashoff RE, et al. Patterns of care related to age of breast cancer patients. JAMA. 1987;257:2766–2770. [PubMed]
25. Hurria A, Lachs MS, Cohen HJ, et al. Geriatric assessment for oncologists: rationale and future directions. Crit Rev Oncol Hematol. 2006;59:211–217. [PubMed]
26. Cohen HJ, Harris T, Pieper CF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med. 2003;114:180–187. [PubMed]
27. Ferrucci L, Corsi A, Lauretani F, et al. The origins of age-related proinflammatory state. Blood. 2005;105:2294–2299. [PubMed]
28. Institute of Medicine. Cancer in Elderly People: Workshop Proceedings. Washington, DC: The National Academies Press; 2007.
29. Lichtman SM, Balducci L, Aapro M. Geriatric oncology: a field coming of age. J Clin Oncol. 2007;25:1821–1823. [PubMed]
30. Nelson W, Stefanek M, Peters E, et al. Basic and applied decision making in cancer control. Health Psychol. 2005;24:S3–S8. [PubMed]
31. Miller SM, Stefanek ME, Bowen DJ, et al. Decision making in the cancer context: an introduction to the special series. Ann Behav Med. 2006;32:169–171.
32. Miller SM, Bowen D, Lyle J, et al. Primary prevention, aging, and cancer: overview and future perspectives. Cancer. 2008;113 (12 suppl):3484–3492. [PMC free article] [PubMed]
33. Sheinfeld Gorin S, Gauthier J, Hay J, Miles A, Wardle J. Cancer screening and aging: research barriers and opportunities. Cancer. 2008;113 (12 suppl):3493–3504. [PubMed]
34. Given B, Given CW. Older adults and cancer treatment. Cancer. 2008;113 (12 suppl):3505–3511. [PMC free article] [PubMed]
35. Trask PC, Blank TO, Jacobsen PB. Future perspectives on the treatment issues associated with cancer and aging. Cancer. 2008;113 (12 suppl):3512–3518. [PubMed]
36. Avis NE, Deimling GT. Cancer survivorship and aging. Cancer. 2008;113 (12 suppl):3519–3529. [PubMed]
37. Bellizzi KM, Mustian KM, Palesh OG, Diefenbach M. Cancer survivorship and aging: moving the science forward. Cancer. 2008;113 (12 suppl):3530–3539. [PMC free article] [PubMed]
38. Saraiya B, Bodnar-Deren S, Leventhal E, Leventhal H. End-of-life planning and its relevance for patients and oncologists’ decisions in choosing cancer therapy. Cancer. 2008;113 (12 suppl):3540–3547. [PMC free article] [PubMed]
39. Reitschuler Cross E, Emanuel L. Providing inbuilt economic resilience options: an obligation of comprehensive cancer care. Cancer. 2008;113 (12 suppl):3548–3555. [PubMed]
40. Peters E, Diefenbach M, Hess TM, Vastfjall D. Age differences in 2 information-processing modes: implications for cancer decision making. Cancer. 2008;113 (12 suppl):3557–3567. [PMC free article] [PubMed]